Article Details
Retrieved on: 2021-04-29 05:12:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Contract drug manufacturer Lonza (LONN.S) plans to double Swiss production capacity for Moderna's (MRNA.O) COVID-19 vaccine, helping the U.S. ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here